E1	Procedure:T1 Name:T2 Temporality:E12 Temporality2:E13
E4	Condition:T4 Name:T5 Temporality:E2
E5	Age:T10 Eq-Comparison:E7
E3	Condition:T15 Name:T16
E7	Eq-Comparison:T17 Value:T12 Operator:T18 Temporal-Unit:T8
E8	Drug:T19 Name:T20
E9	Condition:T21 Name:T22
E10	Eq-Comparison:T23 Temporal-Unit:T9 Operator:T24 Value:T13
E11	And:T25 Arg:T3 Arg2:E3
E12	Eq-Comparison:T26 Temporal-Period:T27
E13	Eq-Comparison:T28 Temporal-Recency:T29
E14	And:T30 Arg:E5 Arg2:E1
E2	Eq-Comparison:T11 Temporal-Period:T14
E6	And:T31 Arg:T7 Arg2:E4
T1	Procedure 244 239	chemotherapy
T2	Procedure-Name 244 239	chemotherapy
T3	Life-Stage-And-Gender 134 130	Children
T4	Condition 500 489	hearing loss
T5	Condition-Name 500 489	hearing loss
T6	Life-Stage-And-Gender 299 292	children
T7	Life-Stage-And-Gender 449 438	Children
T8	Eq-Temporal-Unit 157 152	months
T9	Eq-Temporal-Unit 313 305	years
T10	Age 147 143	aged
T12	Eq-Value 150 145	3
T13	Eq-Value 307 299	8
T15	Condition 142 138	RB
T16	Condition-Name 142 138	RB
T17	Eq-Comparison 167 162	3 months and older
T18	Eq-Operator 167 162	and older
T19	Drug 231 226	IA carboplatin
T20	Drug-Name 231 226	IA carboplatin
T21	Condition 272 265	Retinoblastoma
T22	Condition-Name 272 265	Retinoblastoma
T23	Eq-Comparison 317 309	over 8 years old
T24	Eq-Operator 304 297	over
T25	And 139 135	with
T26	Eq-Comparison 185 180	scheduled
T27	Eq-Temporal-Period 185 180	scheduled
T28	Eq-Comparison 208 203	first
T29	Eq-Temporal-Recency 208 203	first
T30	And 171 166	who
T11	Eq-Comparison 487 476	preexisting
T14	Eq-Temporal-Period 487 476	preexisting
T31	And 454 443	with
A1	Life-Stage-And-Gender-Type T3 child
A2	Life-Stage-And-Gender-Type T6 child
A3	Life-Stage-And-Gender-Type T7 child
A4	Eq-Temporal-Unit-Value T8 month
A5	Eq-Temporal-Unit-Value T9 year
A6	Eq-Operator-Value T18 GTEQ
A7	Eq-Operator-Value T24 GT
A8	Eq-Temporal-Period-Value T27 future
A9	Eq-Temporal-Recency-Value T29 first-time
A10	Eq-Temporal-Period-Value T14 past
R1	Using Arg1:E1 Arg2:E8